RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Chinook Therapeutics Stock

Chinook Therapeutics Employees 2024

Chinook Therapeutics Employees

96

Ticker

KDNY

ISIN

US16961L1061

WKN

A2QE43

In 2024, Chinook Therapeutics employed 96 people, a 0% change from the 96 number of employees in the previous year.

Chinook Therapeutics Aktienanalyse

What does Chinook Therapeutics do?

Chinook Therapeutics Inc. is a biotechnology company focused on the discovery, development, and commercialization of novel therapeutics to treat diseases involving inadequate or faulty kidney function, as well as immune and inflammatory mechanisms. The headquarters of Chinook Therapeutics is located in Seattle, Washington, USA. The company was founded in 2019 by a team of experienced executives in the biotechnology industry, including Tom Frohlich, former Vice President at Omeros Corporation, and Eric Dobmeier and Yi Liu, both formerly with Juno Therapeutics. Chinook Therapeutics aims to improve treatment options for patients with kidney diseases by developing novel therapeutics that influence kidney metabolism and the function of immune and inflammatory mechanisms. Chinook's products are intended to have the potential to slow down or stop the progression of kidney diseases and improve patients' lives. Chinook Therapeutics' business model focuses on supporting the discovery and development of potential therapeutics in the earliest stages to optimize the prospects of later commercialization. The company pursues a pipeline-based strategy that includes a variety of development programs with different focuses. The various divisions of Chinook Therapeutics include the following areas: 1. Therapeutic products for kidney diseases Chinook Therapeutics focuses on the discovery and development of therapeutics for kidney diseases targeting various aspects of kidney metabolism. An example of this is the drug candidate BION-1301, an antibody targeting the binding site of APRIL and BAFF on CD40, with the goal of controlling the progression of glomerulonephritis. 2. Immunology and anti-inflammatory therapeutics Chinook Therapeutics is also specialized in the discovery and development of therapeutics targeting the control of immune and inflammation-related diseases. An example of this is the drug candidate CHN-083, a potent inhibitor of the kinase TRPM8, specifically designed for pain relief in inflammatory conditions. 3. Partnerships with other companies Chinook Therapeutics also collaborates closely with other biotechnology companies and research institutions to accelerate the development of therapeutics and enable the commercialization of innovative products. One such partnership is with Arrowhead Pharmaceuticals, whose RNAi technology Chinook can utilize for developing therapeutics for rare diseases as well as kidney and urinary tract disorders. Chinook Therapeutics has established itself as an innovative biotechnology company driving the development of novel therapeutics in the areas of kidney diseases, immunology, and inflammation. The company relies on a pipeline-based strategy and works closely with other companies and research institutions to efficiently bring its developments to the market. Chinook Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Chinook Therapeutics's Employee Base

Chinook Therapeutics's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Chinook Therapeutics's operational capacity and future potential.

Year-to-Year Comparison

Assessing Chinook Therapeutics's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Chinook Therapeutics's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Chinook Therapeutics’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Chinook Therapeutics stock

How many employees does Chinook Therapeutics have this year?

Chinook Therapeutics has 96 undefined employees this year.

How many employees did Chinook Therapeutics have compared to the previous year?

Compared to the previous year, Chinook Therapeutics had 0% more employees.

What impact did the number of employees have on the company Chinook Therapeutics?

The number of employees has a direct impact on the efficiency and productivity of Chinook Therapeutics. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Chinook Therapeutics?

The number of employees can also have an impact on investors of Chinook Therapeutics, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Chinook Therapeutics affect the company?

An increase in equity of Chinook Therapeutics can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Chinook Therapeutics's equity affect the company?

A reduction in equity of Chinook Therapeutics can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Chinook Therapeutics?

Some factors that can influence the equity of Chinook Therapeutics include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Chinook Therapeutics so important for investors?

The equity of Chinook Therapeutics is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Chinook Therapeutics influence the company?

The number of employees at Chinook Therapeutics can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Chinook Therapeutics evolved in recent years?

In recent years, the number of employees at Chinook Therapeutics has changed by 0.

How many employees does Chinook Therapeutics currently have?

Chinook Therapeutics currently has 96 undefined employees.

Why is the number of employees important for investors of Chinook Therapeutics?

The number of employees is important for investors of Chinook Therapeutics as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Chinook Therapeutics take to change the number of employees?

To change the number of employees, Chinook Therapeutics can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Chinook Therapeutics pay?

Over the past 12 months, Chinook Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Chinook Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Chinook Therapeutics?

The current dividend yield of Chinook Therapeutics is .

When does Chinook Therapeutics pay dividends?

Chinook Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Chinook Therapeutics?

Chinook Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Chinook Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Chinook Therapeutics located?

Chinook Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chinook Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chinook Therapeutics from 10/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.

When did Chinook Therapeutics pay the last dividend?

The last dividend was paid out on 10/3/2024.

What was the dividend of Chinook Therapeutics in the year 2023?

In the year 2023, Chinook Therapeutics distributed 0 USD as dividends.

In which currency does Chinook Therapeutics pay out the dividend?

The dividends of Chinook Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Chinook Therapeutics

Our stock analysis for Chinook Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chinook Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.